Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
PaperCitations, authors & open-access status
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 320 citations, 2021 year and closed oa status.
320
Citations
2021
Year
closed
OA Status